[Live] #Wonderbanned at Wonderland (Psymposia Reacts to Hamilton Morris)
On November 3rd, the "Wonderland Miami" psychedelic conference banned the entire Psymposia team from the event. Compass Pathways consultant Hamilton Morris then took to the stage to distort and misrepresent our research in. Join us for a livestream on Tuesday, Nov 15th @ 6pm ET, where we’ll break it all down.
#WonderBanned at Wonderland Miami (Psymposia Reacts to Hamilton Morris)
#WonderBanned at Wonderland Miami (Psymposia Reacts to Hamilton Morris)
On November 3rd, the "Wonderland Miami" psychedelic conference banned the entire Psymposia team from the event. Compass Pathways consultant Hamilton Morris then took to the stage to distort and misrepresent our research.
On Plus Three #46 - Part One: Right Wing Psychedelia, we discuss Brian Pace and Neşe Devenot's recently published paper: "Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency"
__
Abstract: Recent media advocacy for the nascent psychedelic medicine industry has emphasized the potential for psychedelics to improve society, pointing to research studies that have linked psychedelics to increased environmental concern and liberal politics. However, research supporting the hypothesis that psychedelics induce a shift in political beliefs must address the many historical and contemporary cases of psychedelic users who remained authoritarian in their views after taking psychedelics or became radicalized after extensive experience with them.
We propose that the common anecdotal accounts of psychedelics precipitating radical shifts in political or religious beliefs result from the contextual factors of set and setting, and have no particular directional basis on the axes of conservatism-liberalism or authoritarianism-egalitarianism. Instead, we argue that any experience which challenges a person's fundamental worldview—including a psychedelic experience—can precipitate shifts in any direction of political belief.
We suggest that the historical record supports the concept of psychedelics as “politically pluripotent,” non-specific amplifiers of the political set and setting. Contrary to recent assertions, we show that conservative, hierarchy-based ideologies are able to assimilate psychedelic experiences of interconnection, as expressed by thought leaders like Jordan Peterson, corporadelic actors, and members of several neo-Nazi organizations.
Livestream: A License to Trip? | Thursday, April 22 @ 8:30 PM ET
Livestream: A License to Trip? | Thursday, April 22 @ 8:30 PM ET
Psymposia will break down Rick Doblin’s recent appearance on 2020 presidential candidate Marianne Williamson’s podcast where he discusses MAPS' work with republican congressmen Daniel Crenshaw and Matt Gaetz; requiring a license to use drugs; moving towards MDMA therapy for active duty troops; and dosing hundreds of millions of people in order to bring about a global spiritual awakening.
Search "psychedelics" on YouTube and you're likely to encounter Joe Rogan, Sam Harris and Jordan Peterson—nodes of the now-in-decline Intellectual Dark Web (IDW). Contrary to popular conceptions, psychedelics don't result in more progressive or liberatory values. Plus Three talks about how Psymposia started covering the right wing psychedelic beat.
For more, see: https://www.youtube.com/c/Psymposia
When it comes to psychedelic science, it's "politics prohibited" in order to "advance the field." Instead we have "apolitical" projects:
-MDMA for PTSD (in cops & soldiers)
-Psychedelics for COVID-related mental issues
-Dosing for nature relatedness (in the Anthropocene)
🤡 🍄
The "psychedelic spa" model
If psychedelics are compatible with capitalism in a way that leads to high-priced luxury “spa treatments" limited to the 1% we all lose.
For full length podcast videos, support the show by becoming a member @ patreon.com/psymposia. Subscribe & listen to Plus Three on Apple Podcasts, Google Play, Spotify, Stitcher, and psymposia.com
Nese Devenot on access to psychedelic therapy
Given the sad state of American healthcare, future access to mainstream psychedelic therapy is not guaranteed. Medicalization is slow to act and has an exclusionary history, while psychedelic retreat centers are mostly available to the wealthy.
For full length podcast videos, support the show by becoming a member @ patreon.com/psymposia. Subscribe & listen to Plus Three on Apple Podcasts, Google Play, Spotify, Stitcher, and psymposia.com
For decades, psychedelic science has been an open source, collaborative effort between researchers, non-profits, and universities. But that's changing rapiFor decades, psychedelic science has been an open source, collaborative effort between researchers, non-profits, and universities. But that's changing rapidly as psychedelics go mainstream. The flurry of new for-profit corporations have begun using obstructionist intellectual property (IP) strategies to attract investors and capital.
To this end, COMPASS Pathways attempted to acquire IP by claiming novelty on methods for synthesizing psilocybin originally discovered by Albert Hofmann and Sandoz, which were rejected by both the US and EU patent offices. However, COMPASS succeeded in the US with one patent claim by alleging a thin veneer of novelty - in this case that “novelty" was simply a different crystalline structure. Same molecular structure, ultimately nothing new, but say hello to COMP360, the first patented form of psilocybin for treatment resistant depression.
For full length podcast videos, support the show by becoming a member @ patreon.com/psymposia. Subscribe & listen to Plus Three on Apple Podcasts, Google Play, Spotify, Stitcher, and psymposia.com
This is what "mainstreaming" psychedelics looks like
Making psychedelics "mainstream" means that we’re going to be seeing them fit into mainstream marketing frameworks, and all of the lowest common denominator pop cultural consumerism that comes with it, including patents, Goop, and high-priced retreats.
For full length podcast videos, support the show by becoming a member @ patreon.com/psymposia. Subscribe & listen to Plus Three on Apple Podcasts, Google Play, Spotify, Stitcher, and psymposia.com
Compass Pathways COMP360 psilocybin patent
For decades, psychedelic science has been an open source, collaborative effort between researchers, non-profits, and universities. But that's changing rapiFor decades, psychedelic science has been an open source, collaborative effort between researchers, non-profits, and universities. But that's changing rapidly as psychedelics go mainstream. The flurry of new for-profit corporations have begun using obstructionist intellectual property (IP) strategies to attract investors and capital.
To this end, COMPASS Pathways attempted to acquire IP by claiming novelty on methods for synthesizing psilocybin originally discovered by Albert Hofmann and Sandoz, which were rejected by both the US and EU patent offices. However, COMPASS succeeded in the US with one patent claim by alleging a thin veneer of novelty - in this case that “novelty" was simply a different crystalline structure. Same molecular structure, ultimately nothing new, but say hello to COMP360, the first patented form of psilocybin for treatment resistant depression.
For full length podcast videos, support the show by becoming a member @ patreon.com/psymposia. Subscribe & listen to Plus Three on Apple Podcasts, Google Play, Spotify, Stitcher, and psymposia.com
Accidental livestream, but checkout the #TestIt reagent drug checking panel, hosted by Dancesafe, at The Global Students for Sensible Drug Policy Conference in Chicago!
Adam Strauss presents The Mushroom Cure. | NYC
Processing Trauma with Ayahuasca After My Drug Conviction